임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

32건 표시

3상완료· Essential Hypertension
A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
리드: 대웅제약
상세 →NCT06671392
3상완료· Hypertension
Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
리드: 대웅제약
상세 →NCT06682000
3상완료· Gastro Oesophageal Reflux Disease
Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
협력: 대웅제약
상세 →NCT07326904
3상완료· Colonoscopy
Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;
리드: 대웅제약
상세 →NCT06062030
3상완료· Helicobacter Pylori Infection
Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
리드: 대웅제약
상세 →NCT06751121
3상완료· Hypertension
A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
리드: 대웅제약
상세 →NCT05643508
3상완료· Reflux Esophagitis
The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
리드: 대웅제약
상세 →NCT05813561
3상완료· Dry Eye
A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
협력: 대웅제약
상세 →NCT05109702
3상완료· T2DM (Type 2 Diabetes Mellitus)
Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
리드: 대웅제약
상세 →NCT05376930
3상완료· T2DM (Type 2 Diabetes Mellitus)
Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin
리드: 대웅제약
상세 →NCT05376969
3상완료· Peptic Ulcer
Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
리드: 대웅제약
상세 →NCT04784910
3상완료· T2DM (Type 2 Diabetes Mellitus)
The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
리드: 대웅제약
상세 →NCT04654390
3상완료· T2DM (Type 2 Diabetes Mellitus)
The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.
리드: 대웅제약
상세 →NCT04634500
3상완료· T2DM (Type 2 Diabetes Mellitus)
The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.
리드: 대웅제약
상세 →NCT04632862
3상완료· Moderate to Severe Glabellar Lines
DWP450 for Treating Moderate to Severe Glabellar Lines
리드: 대웅제약
상세 →NCT06354127
3상완료· Acute Gastritis
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
리드: 대웅제약
상세 →NCT04341454
3상완료· Benign Masseteric Hypertrophy
Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
리드: 대웅제약
상세 →NCT04294251
3상완료· Submental Fat
Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat
리드: 대웅제약
상세 →NCT03946592
3상완료· Dry Eye
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
협력: 대웅제약
상세 →NCT03846453
3상완료· Erosive Esophagitis
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)
리드: 대웅제약
상세 →NCT03736369
3상완료· Functional Dyspepsia
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)
리드: 대웅제약
상세 →NCT03184402
3상완료· Hypertension
A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
리드: 대웅제약
상세 →NCT03009487
3상완료· Functional Dyspepsia
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia
리드: 대웅제약
상세 →NCT03024086
3상완료· Type II Diabetes
Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)
리드: 대웅제약
상세 →NCT02947620
3상완료· Gastric Cancer
Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer
리드: 대웅제약
상세 →NCT02490111
3상완료· Spasticity
A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
리드: 대웅제약
상세 →NCT01945684
3상완료· Hypertension
Clinical Study for Patients With Hypertension Associated With Dyslipidemia
리드: 대웅제약
상세 →NCT01764295
3상완료· COPD
Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
리드: 대웅제약
상세 →NCT01636401
3상완료· Moderate to Severe Glabellar Line
Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line
리드: 대웅제약
상세 →NCT01629875
3상완료· Diabetic Foot Ulcer Patients With Uncontrolled Diabetes Mellitus
Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
리드: 대웅제약
상세 →NCT01629199
3상완료· Regeneration of Alveolar Tissue After Maxillary Sinus Floor Augmentation
Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation
리드: 대웅제약
상세 →NCT01634308
3상완료· Growth Hormone Deficiency
Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
리드: 대웅제약
상세 →NCT02693522

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.